← Back

C2N

product 1 mention from 1 sources Visit website →

A commercial blood-based biomarker test for Alzheimer's disease detection and monitoring.

diagnostics biomarkers alzheimers medical testing
Check price →
1

sources

Mentioned by

Peter Attia

All mentions

Peter Attia mentioned ✓ High confidence
"We could look at C2N, we could look at PAL, we could look at any of the other brain metabolomics, we could look at so many things."
From: 381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more • ▶ 1:44:50 • Jan 2026

Attribution: Peter mentions C2N as a biomarker tool that could be used in randomized controlled trials for hormone therapy research